Found 0 matching trials
Attentional Mechanisms in SCD
EARLY_PHASE1This study will use an anticholinergic pharmacological probe to examine att...
Location
Vanderbilt University Medical Center
Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
PHASE2Depressed patients will receive 6 weeks of citaloprma (20-40mg) therapy. Su...
Location
Multiple Locations
Nicotinic Modulation of the Default Network of Resting Brain Function
N/ABackground:
\- A brain circuit called the default network is the brain cir...
Location
National Institute on Drug Abuse, Biomedical Research Center (BRC)
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
PHASE2This is an open-label study evaluating the safety and tolerability of topic...
Location
East Bay Retina Consultants, Inc.
Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
PHASE1The purpose of this study is to examine the safety and efficacy of mecamyla...
TC-5214 as add-on the Treatment of Major Depressive Disorder
PHASE2This is a multi-center, double blind, randomized, placebo-controlled, paral...
Location
Aurora Clinical Trials
Cholinergic Health After Menopause (CHAMP)
EARLY_PHASE1Women are at increased risk for Alzheimer's disease (AD). Notably at menopa...
Location
Vanderbilt University Medical Center
The Nicotinic Cholinergic System and Cognitive Aging
PHASE1Prior research has shown that a chemical system in the brain called the cho...
Location
University of Vermont
To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects
PHASE1The purpose of this study is to assess safety, tolerability and pharmacokin...
Location
Multiple Locations
Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
NAWe are conducting this study to find out if blocking or partially stimulati...
Location
Freedom Trail Clinic, Massachusetts General Hospital